Progress Toward Regional Measles Elimination — Worldwide, 2000–2020

In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030) uses measles incidence as an indicator of the strength of immuniza...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:MMWR. Morbidity and mortality weekly report Ročník 70; číslo 45; s. 1563 - 1569
Hlavní autoři: Dixon, Meredith G., Ferrari, Matt, Antoni, Sebastien, Li, Xi, Portnoy, Allison, Lambert, Brian, Hauryski, Sarah, Hatcher, Cynthia, Nedelec, Yoann, Patel, Minal, Alexander, James P., Steulet, Claudia, Gacic-Dobo, Marta, Rota, Paul A., Mulders, Mick N., Bose, Anindya S., Rosewell, Alexander, Kretsinger, Katrina, Crowcroft, Natasha S.
Médium: Journal Article Newsletter
Jazyk:angličtina
Vydáno: United States Centers for Disease Control & Prevention (CDC) 12.11.2021
U.S. Government Printing Office
U.S. Center for Disease Control
Centers for Disease Control and Prevention
Témata:
Child
Coronaviruses
COVID-19 vaccines
Deaths
Disease Eradication
Disease transmission
Dosage
Elimination
Epidemics
Estimates
Fatalities
Full Report
Global Health - statistics & numerical data
Humans
Immunity
Immunization
Immunization Programs
Incidence
Infant
Measles
Measles - epidemiology
Measles - prevention & control
Measles Vaccine - administration & dosage
Medical laboratories
Mortality
Pandemics
Public health
Regions
Rubella
Surveillance
Vaccination
Vaccines
World Health Organization
Brazil
Nigeria
ISSN:0149-2195, 1545-861X, 1545-861X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:In 2012, the World Health Assembly endorsed the Global Vaccine Action Plan,* with the objective of eliminating measles in five of the six World Health Organization (WHO) regions by 2020 (1). The Immunization Agenda 2021-2030 (IA2030) uses measles incidence as an indicator of the strength of immunization systems. The Measles-Rubella Strategic Framework 2021-2030 and the Measles Outbreaks Strategic Response Plan 2021-2023** are aligned with the IA2030 and highlight robust measles surveillance systems to document immunity gaps, identify root causes of undervaccination, and develop locally tailored solutions to ensure administration of 2 doses of measles-containing vaccine (MCV) to all children. This report describes progress toward World Health Assembly milestones and measles elimination objectives during 2000-2020 and updates a previous report (2). During 2000-2010, estimated MCV first dose (MCV1) coverage increased globally from 72% to 84%, peaked at 86% in 2019, but declined to 84% in 2020 during the COVID-19 pandemic. All countries conducted measles surveillance, although fewer than one third achieved the sensitivity indicator target of ≥2 discarded cases per 100,000 population in 2020. Annual reported measles incidence decreased 88% during 2000-2016, from 145 to 18 cases per 1 million population, rebounded to 120 in 2019, before falling to 22 in 2020. During 2000-2020, the annual number of estimated measles deaths decreased 94%, from 1,072,800 to 60,700, averting an estimated 31.7 million measles deaths. To achieve regional measles elimination targets, enhanced efforts are needed to reach all children with 2 MCV doses, implement robust surveillance, and identify and close immunity gaps.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0149-2195
1545-861X
1545-861X
DOI:10.15585/mmwr.mm7045a1